Nyambe, Hasan, et al. “The Survival Rate Comparison of Non Small Cell Lung Carcinoma Patients Who Are Given by Epidermal Growth Factor Receptor-Tyrosin Kinase Inhibitor and Those Given by First-Line Chemotherapy Treatment”. Nusantara Medical Science Journal, vol. 6, no. 2, Jan. 2022, pp. 103-15, doi:10.20956/nmsj.v6i2.18857.